Bispecific anti-EGFR/anti IGF-1R antibodies

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9650442
APP PUB NO 20140193415A1
SERIAL NO

14220952

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to bispecific anti-EGFR/anti IGF-1R antibodies, methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ROCHE GLYCART AGWAGISTRASSE 18 SCHLIEREN 8952

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hosse, Ralf Cham, CH 86 1599
Klein, Christian Bonstetten, CH 571 9941
Moessner, Ekkehard Kreuzlingen, CH 194 2920
Schanzer, Juergen Michael Munich, DE 37 1332
Shao, Cuiying Aberdeen, GB 6 29
Shi, Lei Shanghai, CN 557 2723
Umana, Pablo Wollerau, CH 247 5409
Wang, Peng Shanghai, CN 1420 6748
Wartha, Katharina Munich, DE 12 281

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 16, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00